Загрузка...
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of live-attenuated vi...
Сохранить в:
| Опубликовано в: : | Vaccine |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Published by Elsevier Ltd.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7563577/ https://ncbi.nlm.nih.gov/pubmed/33070999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.09.042 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|